| Recruiting | Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patie Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis | Phase 2 / Phase 3 | 2025-08-19 |
| Not Yet Recruiting | Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk T Adult Pleomorphic Rhabdomyosarcoma, AJCC Grade 2 Sarcoma, AJCC Grade 3 Sarcoma | N/A | 2025-01-28 |
| Recruiting | Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer Refractory Differentiated Thyroid Gland Carcinoma | Phase 3 | 2024-08-22 |
| Withdrawn | Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carbopl Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma | Phase 2 | 2024-04-12 |
| Recruiting | Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, Th Glioblastoma, IDH-Wildtype | Phase 2 | 2024-04-11 |
| Recruiting | Cost Communication and Financial Navigation in Cancer Patients (COSTCOM) Malignant Solid Neoplasm | N/A | 2024-02-29 |
| Recruiting | Mobile Health for Adherence in Breast Cancer Patients Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma | N/A | 2024-01-26 |
| Recruiting | Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Al Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8 | Phase 3 | 2023-10-19 |
| Recruiting | Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors Hodgkin Lymphoma, Non-Hodgkin Lymphoma | — | 2023-10-13 |
| Active Not Recruiting | Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 3 | 2023-09-07 |
| Active Not Recruiting | Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma | Phase 3 | 2023-06-08 |
| Active Not Recruiting | Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma | Phase 2 | 2023-05-10 |
| Active Not Recruiting | Intravesical BCG vs GEMDOCE in NMIBC Non-muscle-invasive Bladder Cancer | Phase 3 | 2023-02-07 |
| Active Not Recruiting | To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monit Prostate Carcinoma | Phase 2 | 2021-10-05 |
| Terminated | Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Phase 2 | 2021-09-22 |
| Terminated | Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Phase 2 | 2021-06-01 |
| Active Not Recruiting | Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery fo Prostate Carcinoma | Phase 3 | 2021-03-01 |
| Recruiting | Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Tri Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma | Phase 3 | 2021-02-24 |
| Active Not Recruiting | Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladde Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 | Phase 2 / Phase 3 | 2021-02-24 |
| Active Not Recruiting | Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 2 | 2021-02-09 |
| Terminated | Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Steroid-Refractory Pneumonitis | Phase 2 | 2021-01-07 |
| Active Not Recruiting | Cancer and Blood Pressure Management, CARISMA Study Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma | N/A | 2020-10-29 |
| Recruiting | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma | Phase 3 | 2020-10-08 |
| Active Not Recruiting | Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma | Phase 2 | 2020-09-15 |
| Active Not Recruiting | Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Lipo Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | 2020-08-26 |
| Active Not Recruiting | Comparing Two Methods to Follow Patients With Pancreatic Cysts Pancreatic Carcinoma | N/A | 2020-06-16 |
| Active Not Recruiting | Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Ga Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 | Phase 3 | 2020-05-26 |
| Active Not Recruiting | CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Thera Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8 | Phase 2 | 2020-03-13 |
| Active Not Recruiting | Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma | Phase 2 | 2020-01-02 |
| Active Not Recruiting | A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lym Liver Lymphoma, Mantle Cell Lymphoma | Phase 2 | 2019-12-13 |
| Recruiting | Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Mye Smoldering Plasma Cell Myeloma | Phase 3 | 2019-09-16 |
| Active Not Recruiting | Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 | Phase 2 | 2019-08-09 |
| Completed | Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices Carcinoma In Situ, Current Smoker, Malignant Neoplasm | N/A | 2019-08-01 |
| Active Not Recruiting | Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemi Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease | Phase 2 | 2019-06-26 |
| Recruiting | Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 | Phase 2 | 2019-03-12 |
| Active Not Recruiting | Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer Prostate Carcinoma | N/A | 2019-02-11 |
| Withdrawn | Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Commun Breast Carcinoma, Colorectal Carcinoma, Community Practice | — | 2019-01-08 |
| Terminated | Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma | N/A | 2018-12-13 |
| Active Not Recruiting | Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblast Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma | Phase 1 / Phase 2 | 2018-08-13 |
| Active Not Recruiting | Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, Stage II Colon Cancer AJCC v8 | — | 2018-06-11 |
| Active Not Recruiting | Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients W Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue | Phase 2 | 2018-04-26 |
| Active Not Recruiting | Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Man Mantle Cell Lymphoma | Phase 3 | 2017-11-27 |
| Active Not Recruiting | Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer Breast Screening | Phase 3 | 2017-09-28 |
| Active Not Recruiting | Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia Acute Promyelocytic Leukemia With PML-RARA, t(15;17) | N/A | 2017-09-26 |
| Active Not Recruiting | DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma Gliosarcoma, Recurrent Glioblastoma | N/A | 2017-07-25 |
| Active Not Recruiting | Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts Asymptomatic | N/A | 2016-12-27 |
| Recruiting | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma | Phase 2 | 2016-11-23 |
| Completed | Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients Advanced Malignant Neoplasm, Locally Advanced Malignant Neoplasm | N/A | 2016-10-25 |
| Active Not Recruiting | Reproductive Health Program in Patients With Cancer Malignant Neoplasm | N/A | 2016-09-02 |
| Unknown | Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Local Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma | Phase 2 | 2016-08-23 |
| Withdrawn | Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Stage IIIA Non-Small Cell Lung Cancer | Phase 2 | 2015-11-19 |
| Active Not Recruiting | Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated ( Gastric Neuroendocrine Carcinoma, Intestinal Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Carcinoma | Phase 2 | 2015-11-06 |
| Active Not Recruiting | Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma | Phase 3 | 2015-10-20 |
| Completed | Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer High Grade Upper Tract Urothelial Carcinoma | Phase 2 | 2015-08-27 |
| Active Not Recruiting | MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Ductal Breast Carcinoma In Situ | N/A | 2015-03-25 |
| Active Not Recruiting | Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive | Phase 3 | 2015-03-23 |
| Terminated | Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of th Head and Neck Squamous Cell Carcinoma | Phase 2 | 2014-06-30 |
| Terminated | Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With S Gastrinoma, Glucagonoma, Insulinoma | Phase 2 | 2014-04-10 |
| Active Not Recruiting | Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Trea Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx | Phase 2 | 2014-01-22 |
| Completed | Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cance Recurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer | Phase 1 / Phase 2 | 2014-01-15 |
| Active Not Recruiting | Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multip Plasma Cell Myeloma | Phase 3 | 2013-12-06 |
| Active Not Recruiting | Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Gastrinoma, Glucagonoma, Insulinoma | Phase 2 | 2013-08-08 |
| Active Not Recruiting | A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer | N/A | 2013-06-11 |
| Terminated | Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Lymphoma | Phase 2 | 2013-05-24 |
| Completed | Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 Leukemia | — | 2012-04-17 |
| Completed | Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lym Lymphoma | — | 2012-02-06 |
| Completed | Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Melanoma (Skin) | — | 2012-01-19 |
| Completed | Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial Lymphoma | — | 2011-12-15 |
| Completed | Biomarkers in Patients With Head and Neck Cancer Head and Neck Cancer | — | 2011-11-21 |
| Terminated | Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia | Phase 2 | 2011-04-27 |
| Completed | Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab Breast Cancer | — | 2011-04-05 |
| Completed | Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lena Lymphoma | Phase 2 | 2011-02-09 |
| Completed | Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690 Melanoma (Skin) | — | 2011-02-08 |
| Completed | Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Old Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 3 | 2011-02-04 |
| Completed | BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newl Lung Cancer | Phase 2 | 2011-01-17 |
| Completed | Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Breast Cancer, Stage IV Breast Cancer | Phase 2 | 2011-01-07 |
| Completed | Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With A Lung Cancer | Phase 3 | 2010-10-25 |
| Completed | Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer Th Kidney Cancer | Phase 2 | 2010-09-17 |
| Completed | Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cel Head and Neck Cancer | — | 2010-08-05 |
| Completed | Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head an Head and Neck Cancer | — | 2010-08-05 |
| Completed | Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytar Leukemia | — | 2010-07-08 |
| Completed | Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With S Lung Cancer | — | 2010-06-13 |
| Completed | Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Withou Lymphoma | — | 2010-04-21 |
| Completed | Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With Erlotinib H Lung Cancer | — | 2010-04-12 |
| Completed | Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ Breast Cancer | — | 2010-03-05 |
| Completed | Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia Leukemia | — | 2009-05-15 |
| Completed | Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clini Prostate Cancer | — | 2008-07-10 |
| Completed | Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Ca Head and Neck Cancer | — | 2008-07-08 |
| Completed | Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer Breast Cancer | — | 2008-06-17 |
| Completed | Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | — | 2008-03-15 |
| Completed | Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Pa Lung Cancer | — | 2008-03-14 |
| Completed | Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy Melanoma (Skin) | — | 2008-01-14 |
| Completed | Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia Leukemia | — | 2007-10-26 |
| Completed | Study of Biomarkers Using Tissue Samples From Older Patients With Diffuse Large B-Cell Lymphoma Treated With C Lymphoma | — | 2007-09-24 |
| Completed | Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab Colorectal Cancer | — | 2007-07-24 |
| Completed | Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma Melanoma (Skin) | — | 2007-06-01 |
| Completed | Genes in Predicting Outcome in Patients With Esophageal Cancer Treated With Cisplatin, Radiation Therapy, and Esophageal Cancer | — | 2007-05-11 |
| Completed | Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 Lymphoma | — | 2007-04-18 |
| Completed | Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lu Lung Cancer | — | 2007-04-13 |
| Completed | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Anal Cancer | Phase 2 | 2007-02-28 |
| Completed | Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin Colorectal Cancer | — | 2007-01-03 |
| Completed | DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia Leukemia | — | 2006-12-28 |
| Completed | Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Metastatic Hormone-sensitive Prostate Cancer | Phase 3 | 2006-09-26 |
| Completed | Study of DNA Samples From Patients With Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | — | 2006-07-06 |
| Completed | DNA Changes in Patients With Prostate Cancer Prostate Cancer | — | 2006-05-23 |
| Terminated | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer | Phase 3 | 2006-05-11 |
| Completed | Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia Leukemia | — | 2006-03-28 |
| Completed | DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia Leukemia | — | 2006-03-23 |
| Completed | HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Tr Lung Cancer | — | 2006-02-02 |
| Completed | Levocarnitine in Treating Fatigue in Cancer Patients Fatigue, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | 2005-12-16 |
| Terminated | FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma Malignant Melanoma, Melanoma | Phase 2 | 2005-10-04 |
| Completed | Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Lung Cancer | Phase 3 | 2000-12-18 |
| Completed | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer Gastric Cancer | Phase 2 | 1999-06-01 |
| Active Not Recruiting | High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma Melanoma (Skin) | Phase 3 | 1999-03-25 |
| Completed | Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck Head and Neck Cancer | — | 1996-04-30 |
| Terminated | Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Colorectal Cancer | Phase 3 | 1993-10-01 |